B&D White Capital Company, LLC Amgen Inc Transaction History

B&D White Capital Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $128,562 - $152,022	600 Added 6.98%	9,200 $2.04 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $1.94 Million - $2.37 Million	8,600 New	8,600 $2.08 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $4.9 Million - $5.61 Million	-24,628 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $4.38 Million - $5.13 Million	20,628 Added 515.7%	24,628 $5.24 Million
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $934,320 - $1.04 Million	4,000 New	4,000 $975,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $22,191 - $25,860	-100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $21,638 - $25,767	100 New	100 $22,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of B&D White Capital Company, LLC, based on Form 13F filings with the SEC.

Stay updated on B&D White Capital Company, LLC with notifications on news.